-+ 0.00%
-+ 0.00%
-+ 0.00%

SCYNEXIS Announces Upcoming Presentations Highlighting Data On Second-Gen Fungerp Drug Candidate, SCY-247, At 2026 IMARI

Benzinga·01/28/2026 13:05:44
Listen to the news

SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant infections, today announced upcoming presentations highlighting data on the Company's second-generation fungerp drug candidate, SCY-247, at the inaugural Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI), which is taking place from January 28 to 30, 2026, in Las Vegas, Nevada.